Biotage AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SEK 401 million compared to SEK 305 million a year ago. Net income was SEK 65 million compared to SEK 53 million a year ago. Basic earnings per share from continuing operations was SEK 0.99 compared to SEK 0.81 a year ago. Diluted earnings per share from continuing operations was SEK 0.98 compared to SEK 0.81 a year ago.
For the nine months, sales was SEK 1,182 million compared to SEK 890 million a year ago. Net income was SEK 194 million compared to SEK 159 million a year ago. Basic earnings per share from continuing operations was SEK 2.94 compared to SEK 2.44 a year ago. Diluted earnings per share from continuing operations was SEK 2.93 compared to SEK 2.44 a year ago.